XML 29 R17.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation
6 Months Ended
Dec. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock-Based Compensation

(10) Stock-Based Compensation

 

Stock Option Activity Summary

 

The Company’s stock option activity for the six months ended December 31, 2020 is as follows:

 

 

 

Shares

(in thousands)

 

 

Weighted Average

Exercise Price

 

Outstanding at June 30, 2020

 

 

325

 

 

$

5.68

 

Granted

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

Canceled or expired

 

 

(4

)

 

 

5.30

 

Outstanding at December 31, 2020

 

 

321

 

 

$

5.68

 

 

The aggregate intrinsic value of options exercisable at December 31, 2020 was $0, as the fair value of the Company’s common stock is less than the exercise prices of these options. The remaining stock-based compensation expense of $2 thousand related to stock options will be recognized over a weighted-average period of 1.78 years.

 

The table below details the Company’s stock options outstanding as of December 31, 2020:

 

Range of exercise prices

 

Number

Outstanding

 

 

Options

Outstanding

Weighted-

Average

Remaining

Contractual

Life (years)

 

 

Weighted-

Average

Exercise

Price

 

 

Number

Exercisable

 

 

Options

Exercisable

Weighted-

Average

Exercise

Price

 

$1.85 – 3.55

 

 

76,500

 

 

 

2.28

 

 

$

3.43

 

 

 

66,500

 

 

$

3.43

 

$5.30 – 5.85

 

 

114,725

 

 

 

6.36

 

 

 

5.49

 

 

 

113,203

 

 

 

5.49

 

$6.00 – 8.35

 

 

130,000

 

 

 

3.89

 

 

 

7.19

 

 

 

86,000

 

 

 

6.59

 

$1.85 – 8.35

 

 

321,225

 

 

 

4.39

 

 

$

5.68

 

 

 

265,703

 

 

$

5.33

 

 

Compensation costs recognized related to stock option awards were $0 and $41 thousand for the three months ended December 31, 2020, and 2019, respectively and $1 thousand and $85 thousand for the six months ended December 31, 2020 and 2019, respectively.

 

Restricted Stock

 

The Company’s restricted stock activity for the six months ended December 31, 2020, is as follows:

 

 

 

Shares

(in thousands)

 

 

Weighted

Average

Grant-Date

Fair Value

 

Outstanding at June 30, 2020

 

 

133

 

 

$

3.95

 

Granted

 

 

 

 

 

 

Vested

 

 

(54

)

 

 

1.79

 

Canceled or expired

 

 

(23

)

 

 

5.40

 

Outstanding at December 31, 2020

 

 

56

 

 

$

3.92

 

 

Stock compensation expenses related to restricted stock were $46 thousand and $42 thousand for the three months ended December 31, 2020, and 2019, respectively and $90 thousand and $102 thousand for the six months ended December 31, 2020 and 2019, respectively. The remaining stock-based compensation expense of $161 thousand related to restricted stock awards granted will be recognized over a weighted-average period of 0.98 years.